Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Neutralization
57%
Spike
48%
Monospecific Antibody
46%
COVID-19
45%
Neutralizing Antibody
31%
Vaccine Efficacy
27%
Monoclonal Antibodies
26%
Breakthrough Infection
22%
Epitope
21%
Immunity
18%
Antibody Response
16%
Immunity
13%
Mutation
13%
Amino Terminal Sequence
11%
Receptor Binding
10%
Virus
10%
Antigen
10%
Human
9%
Host
8%
Natural Killer Cell
8%
Sample
7%
Metabolite
7%
Dynamics
7%
Hantavirus
7%
Cell Function
7%
Nipah Virus
7%
Flow
7%
Association
7%
New World Arenavirus
7%
Immunology
7%
Heme
7%
Dose
6%
Immune Response
6%
B Cell
5%
T Cell Receptor
5%
Comprehension
5%
Medicine and Dentistry
Infection
59%
COVID-19
30%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Vaccine
24%
Antibody
24%
Symptom
16%
Patient
16%
Monoclonal Antibody
15%
Neutralizing Antibody
15%
T-Cell Response
15%
Disease
15%
B Cell
11%
Antibody Response
11%
Epitope
10%
Assay
10%
Immunity
10%
Hospital
9%
Inpatient
9%
Diagnosis
8%
Evaluation Study
8%
Child
8%
Amino Terminal Sequence
8%
Immunogenicity
8%
Association
7%
Neonates
7%
Chronic Myelogenous Leukemia
7%
Single Drug Dose
7%
Assessment
7%
Observational Study
7%
mRNA Vaccine
7%
Prognosis
7%
Lymphocyte Antigen Receptor
7%
Patient with Cancer
7%
Interim Analysis
7%
Serositis
7%
Syndrome
7%
Immunology
7%
Immunoassay
7%
Heme
7%
Metabolite
7%
T Cell
7%
Receptor Binding
5%
T Lymphocyte Receptor
5%
Biochemistry, Genetics and Molecular Biology
Antibody
30%
Spike
20%
SARS Coronavirus
19%
Immunity
17%
Neutralizing Antibody
16%
Metabolite
15%
N-Terminus
13%
Association
7%
Hantavirus
7%
Angiotensin
7%
Nipah Virus
7%
Lysozyme
7%